HSPB1 and breast carcinoma: HSPB1 overexpression inhibited while HSPB1 knockdown increased erastin-induced intracellular concentrations of lipid ROS in breast cancer cells (Supplementary Fig. S5B, C), which is one of the significant signatures of ferroptosis.